In contrast to non-small cell lung cancer (NSCLC), SCLC is staged as either limited-stage disease (LD) or extensive-stage disease (ED). Chemotherapy remains the essential component for treatment of all patients with SCLC, regardless of stage or performance status. In LD, the addition of ...
small cell lung cancer; treatment Abstract: Lung cancer was relatively uncommon at the turn of the 20th century, and has increased in prevalence at alarming rates, particularly because of the augmented trend in smoking, so that it is now the most common cause of cancer death in the world. ...
The AJMC® Lung Cancer compendium is a comprehensive resource for clinical news and expert insights for the condition.
Small-cell lung cancer: Treatment progress and prospects - The Clark/Ihde article reviewed FA Greco - 《Oncology》 被引量: 3发表: 1998年 Survival and prognostic factors inresected N2 non - small cell lung cancer. Background. The selection of stage IIIA N2 non-small cell lung cancer patients...
EORTC(European Organization for Research and Treatment of Cancer)的一项研究,将对化疗有反应的患者随机化分为2组,接受PCI或不接受PCI,发现PCI治疗组1年生存率为27.1%,未接受PCI者为13.3%。[49]在该研究中,PCI不仅减少脑转移的发生率也提高无病生存率和总体生存率。然而,欧洲肿瘤医学学会(ESMO)2010年的实践...
Small-Cell Lung Cancer Treatment Some of the most commonly used combinations of medications used for SCLC are carboplatin (Paraplatin), cisplatin(Platinol- AQ), cyclophosphamide (Cytoxan), docetaxel (Taxotere), doxorubicin (Adriamycin,Rubex), etoposide (Vepesid),irinotecan(Camptosar), lurbinectedin...
[5] Santos ES.Treatment options after first-line immunotherapy in metastatic NSCLC.Expert Rev Anticancer Ther.2020 Mar;20(3):221-228. [6] Datopotamab deruxtecan (Dato-DXd) in patients with previously treated advanced ...
Only 15% of lung cancer cases are small-cell lung cancer (SCLC). SCLC grows quickly and has often spread to other organs by the time it is diagnosed. Learn about staging, life expectancy, symptoms, causes, treatment, and causes.
ResearchOpen Access04 Sept 2024 Cell Discovery Volume: 10, P: 93 Stimulation of cGAS-STING pathway as a challenge in the treatment of small cell lung cancer: a feasible strategy? Giulia Miglietta Marco Russo Jessica Marinello ReviewsOpen Access31 Aug 2024 British Journal of Cancer Volume: ...
Treatment of advanced non small cell lung cancer [J]. J Thorac Dis, 2011, 3(2): 122-133.Maria AB,Clorinda S,Antonio R.Treatment of advanced non-small cell lung cancer.J Thorac Dis. 2011De Petris L, Crino L, Scagliotti GV, et al. Treatment of advanced non-small cell lung cancer. ...